FUJIFILM Diosynth Biotechnologies Denmark ApS

CVR 26060702 · Private limited company (ApS) · Active · Low risk

FUJIFILM Diosynth Biotechnologies Denmark ApS is a Private limited company (ApS), founded on , based in Hillerød. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 5 more than six months after the end of the financial year. The latest annual report (31 Mar 2026) shows equity of DKK 6.3bn and a net result of DKK -179.9m. CEO: Christian Ørsøe Houborg.

Bankruptcy risk for FUJIFILM Diosynth Biotechnologies Denmark ApS

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 18% of active Danish companies

Lowest riskHighest risk

Increases the risk

CEO changes in the last year2+ · bankruptcy rate 18.5%2.1×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO< 0.5 yrs · bankruptcy rate 11.6%1.3×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Auditor's statementAndet · bankruptcy rate 0.0%0.00×
Reporting classReporting class C, stor virksomhed · bankruptcy rate 1.1%0.13×
Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Employees (latest year)100+ · bankruptcy rate 2.3%0.27×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Gross profit growth0%–10% · bankruptcy rate 3.5%0.39×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
26060702
Status
Active
Company type
Private limited company (ApS)
Founded
(25 years)
Address
Biotek Allé 1
3400 Hillerød
Municipality
Hillerød
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 390k
Employees
728 (2018)
Auditor
KPMG P/S
Audit opted out
No

Warning signs

Annual reports filed late6 of 25
Missing annual reportNo
Negative equityNo
Equity ratio19.5%
Current ratio147%
Moves (last 2 years)0
CEO changes in total13
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year202620252024
RevenueDKK 5.9bnDKK 4.8bnDKK 4.3bn
Gross profitDKK 1.0bnDKK 1.0bnDKK 1.3bn
Net profitDKK -179.9mDKK 165.1mDKK 400.2m
EquityDKK 6.3bnDKK 5.1bnDKK 4.9bn
Total assetsDKK 32.5bnDKK 26.7bnDKK 20.5bn
CashDKK 62.7mDKK 934.8m–
Short-term debtDKK 3.2bnDKK 3.2bn–
Tax owed–DKK 0–
Avg. employees2,1021,761–

Latest annual report: Reporting class C, stor virksomhed · auditor's statement: Independent Auditor’s Report · KPMG Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Apr 2025 – 31 Mar 2026192 Late
1 Apr 2024 – 31 Mar 2025186 Late
1 Apr 2023 – 31 Mar 2024184 Late
1 Apr 2022 – 31 Mar 2023182
1 Apr 2021 – 31 Mar 2022187 Late
1 Apr 2020 – 31 Mar 2021156
1 Jan 2019 – 31 Mar 2020220 Late
1 Jan 2018 – 31 Dec 2018149
1 Jan 2017 – 31 Dec 2017150
1 Jan 2016 – 31 Dec 2016153
1 Jan 2015 – 31 Dec 2015146
1 Jan 2014 – 31 Dec 2014140
1 Jan 2013 – 31 Dec 2013135
1 Jan 2012 – 31 Dec 2012153
1 Jan 2011 – 31 Dec 2011153
1 Jan 2010 – 31 Dec 2010153
1 Jan 2009 – 31 Dec 2009151
1 Jan 2008 – 31 Dec 2008155
1 Jan 2007 – 31 Dec 2007155
1 Jan 2006 – 31 Dec 2006155

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOChristian Ørsøe HouborgCurrent
CEOPeter Rützou-Hjelmkrone
CEOFrancis Marsland
CEORandolph Lee Spicochi
CEOAndrew Orkney Stober
CEOMarianne Leth
CEOLars Petersen
BoardChristian Ørsøe HouborgCurrent
BoardToshihisa IidaCurrent
BoardMasataka AkiyamaCurrent
BoardPatrick John Paul Coleman
BoardSylvie Gregoire
BoardThomas Bucknum
BoardWolfgang Berthold
BoardJohny Humaloja
BoardMichael David Kowolenko
BoardAlasdair James Shepherd
BoardRobert Andrew Hamm
BoardPeter Johan Lindborg
BoardCraig Alan Beasley
BoardAlasdair Shepherd
BoardJohn Cox
BoardInga Birgitte Thygesen
BoardEsther Maria Alegria
BoardAndrew Orkney Stober
BoardMarianne Leth
BoardAllan Frank Fischer Petersen
BoardLars Petersen
BoardTakatoshi Ishikawa
BoardMasato Yamamoto
BoardSteve Bagshaw
BoardMartin Edward Meeson
BoardToshihisa Iida
BoardYoshiki Kimura
Owner (100%)FUJIFILM Diosynth Biotechnologies Holdings Denmark ApSCurrent
AuditorKPMG P/SCurrent
AuditorPricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab
AuditorPRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderBiotech ManufacturingCurrent

The CEOs' other companies

Christian Ørsøe Houborg – 3 other companies

Peter Rützou-Hjelmkrone – 3 other companies

Lars Petersen – 1 other companies

Address history (3 moves)

Biotek Allé 1, 3400 Hillerød
Biogen Idec Alle 1, 3400 Hillerød
Trollesmindealle 27, 3400 Hillerød
Lyngbyvej 28, 2100 København Ø

Former names

FUJIFILM Diosynth Biotechnologies Denmark ApS – now
BIOGEN (DENMARK) MANUFACTURING ApS –
BIOGEN IDEC (DENMARK) MANUFACTURING ApS –
BIOGEN (DENMARK) MANUFACTURING ApS –

Employees per year

Number of employees at FUJIFILM Diosynth Biotechnologies Denmark ApS per year3647282011: 24020112012: 41720122013: 51720132014: 57220142015: 63120152016: 62420162017: 72620172018: 7282018

Other companies at the same address

Similar companies in Hillerød

Questions and answers about FUJIFILM Diosynth Biotechnologies Denmark ApS

Has FUJIFILM Diosynth Biotechnologies Denmark ApS gone bankrupt?

No, FUJIFILM Diosynth Biotechnologies Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of FUJIFILM Diosynth Biotechnologies Denmark ApS?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the CEO of FUJIFILM Diosynth Biotechnologies Denmark ApS?

Christian Ørsøe Houborg is the CEO of FUJIFILM Diosynth Biotechnologies Denmark ApS.

Who is the auditor of FUJIFILM Diosynth Biotechnologies Denmark ApS?

FUJIFILM Diosynth Biotechnologies Denmark ApS most recently used KPMG P/S.

When was FUJIFILM Diosynth Biotechnologies Denmark ApS founded?

FUJIFILM Diosynth Biotechnologies Denmark ApS was founded on 1 June 2001.

What is the equity of FUJIFILM Diosynth Biotechnologies Denmark ApS?

Equity was DKK 6.3bn according to the annual report for the period ending 31 March 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.